Sangamo Therapeutics (SGMO) Earnings Date, Estimates & Call Transcripts $2.16 -0.20 (-8.47%) (As of 01:03 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Sangamo Therapeutics Latest Earnings SummaryUpcoming Q4 Earnings DateMar. 12EstimatedActual EPS (Nov. 12) $0.04 Beat By $0.07 Consensus EPS (Nov. 12) -$0.03 Sangamo Therapeutics issued Q3 2024 earnings on November 12, 2024, reporting an EPS of $0.04, which beat the consensus estimate of -$0.03 by $0.07. Quarterly revenue was reported to be $49.41 million, above analysts' expectations of $26.55 million. With a trailing EPS of -$0.75, Sangamo Therapeutics' earnings are expected to grow next year, from ($0.52) to ($0.11) per share. Conference Call TranscriptConference Call AudioEarnings Press ReleaseEarnings Slide DeckPowered by SGMO Upcoming EarningsSangamo Therapeutics' next earnings date is estimated for Wednesday, March 12, 2025, based off prior year's reporting schedules. Get Sangamo Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sangamo Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSGMO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SGMO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Porter & CompanyUrgent: This election is riggedIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Sangamo Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.26-$0.10-$0.18Q2 20242-$0.17-$0.10-$0.14Q3 20242-$0.14$0.02-$0.06Q4 20241$0.07$0.07$0.07FY 20247-$0.50-$0.11-$0.31Q1 20251-$0.05-$0.05-$0.05Q2 20251-$0.04-$0.04-$0.04Q3 20251-$0.04-$0.04-$0.04Q4 20251$0.07$0.07$0.07FY 20254($0.06)($0.06)($0.06) Sangamo Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 3/12/2025(Estimated)-------11/12/2024Q3 2024-$0.03$0.04+$0.07$0.04$26.55M$49.41M8/6/2024Q2 2024-$0.16-$0.17 -$0.01-$0.16$11.40M$0.36M5/9/2024Q1 2024-$0.22-$0.27 -$0.05-$0.27$8.51M$0.48M3/13/2024Q4 2023-$0.25-$0.34 -$0.09-$0.34$8.96M$2.04M11/1/2023Q3 2023-$0.33-$0.34 -$0.01-$0.09$10.17M$9.40M8/8/2023Q2 2023-$0.35-$0.37 -$0.02-$0.08$22.33M$6.84M Get the Latest News and Ratings for SGMO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sangamo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/8/2023Q1 2023$0.14$0.12 -$0.02$0.12$158.00M$157.96M2/22/2023Q4 2022-$0.36-$0.32+$0.04-$0.32$26.86M$27.23M Sangamo Therapeutics Earnings - Frequently Asked Questions When is Sangamo Therapeutics's earnings date? Sangamo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 12th, 2025 based off last year's report dates. Learn more on SGMO's earnings history. Did Sangamo Therapeutics beat their earnings estimates last quarter? In the previous quarter, Sangamo Therapeutics (NASDAQ:SGMO) reported $0.04 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.03) by $0.07. Learn more on analysts' earnings estimate vs. SGMO's actual earnings. How can I listen to Sangamo Therapeutics's earnings conference call? The conference call for Sangamo Therapeutics's latest earnings report can be listened to online. Listen to Conference Call How can I read Sangamo Therapeutics's conference call transcript? The conference call transcript for Sangamo Therapeutics's latest earnings report can be read online. Read Transcript How much revenue does Sangamo Therapeutics generate each year? Sangamo Therapeutics (NASDAQ:SGMO) has a recorded annual revenue of $176.23 million. How much profit does Sangamo Therapeutics generate each year? Sangamo Therapeutics (NASDAQ:SGMO) has a recorded net income of -$257.83 million. SGMO has generated -$0.75 earnings per share over the last four quarters. What is Sangamo Therapeutics's EPS forecast for next year? Sangamo Therapeutics's earnings are expected to grow from ($0.52) per share to ($0.11) per share in the next year. More Earnings Resources from MarketBeat Related Companies MannKind Earnings Date Celldex Therapeutics Earnings Date Dynavax Technologies Earnings Date BioCryst Pharmaceuticals Earnings Date Myriad Genetics Earnings Date Novavax Earnings Date Innoviva Earnings Date OPKO Health Earnings Date Ironwood Pharmaceuticals Earnings Date Emergent BioSolutions Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report Urgent: This election is rigged (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. This page (NASDAQ:SGMO) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sangamo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sangamo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
